Search Results for: pets and hemp

Natural Pet Science Launches Pet Treats Made From Hemp And Crickets

CANADA: Premium pet brand Natural Pet Science has launched a line of hemp-based health-conscious pet treats infused with crickets – yes, crickets! – to provide a one-of-a-kind snacking experience for pets. The launch features two of the Vancouver-based brand’s inaugural pet treats: Slim’Dog, a weight control formula for dogs, and Calm’Cat, a calming formula for cats. Both pet treat formulas bolster a rich supply of protein and Omega-3 and Omega-6 fatty acids tailored for dogs and cats, thanks to their unique hemp- and cricket-based blends. Mixed with pet-friendly ingredients readily-sourced from Mother Nature, like sweet potatoes, lentils, chickpeas, and coconut meal, these treats are super healthy, yummy, and good for the environment.

So why hemp? Hemp is a “superfood” known to be an excellent non-meat protein source alternative because it’s packed with rich nutrients and minerals essential for a healthy diet, including Omega-3 and Omega-6 fatty acids. Natural Pet Science incorporates different variations of the hemp plant in its pet treat formulas – all of which boost the nutritional value of every Natural Pet Science treat.

Screenshot 2018-06-29 09.35.34But that’s not the only ‘super ingredient’ in Natural Pet Science treats. The forward-thinking brand incorporates crickets in its recipes to give the treats another nutritional mega-boost. Not only do crickets boast a whopping nine different essential amino acids, but these critters are also very eco-friendly. They produce 80 times less methane than cattle-sourced protein and require 10 times less water for each kilogram of protein they produce. That is a massive reduction in carbon impact, packing in protein with far less harm to Mother Nature.

The sustainability of Natural Pet Science’s ingredients is a conscious choice by the brand as it encourages owners and their pets to live a more natural and healthier lifestyle. Plus, crickets are just fun to eat.

“The idea was to give our beloved family cat, Hammie, the same benefits our human clients have been getting,” Ciska Asriel, co-founder of the brand’s parent company EastWest Science, says. “As animal lovers, we were disappointed by the lack of all-natural plant-based options available in today’s pet treat market, so we set out to produce an alternative for people that is healthy for their pets and healthy for the environment using unique ingredients like hemp and crickets.”

 

Natural Pet Science’s Slim’Dog is a healthy and tasty option for dog owners worried about their pooch maintaining a stable weight but who still want to shower their pet with yummy treats. The weight control hemp- and cricket-based formula contains natural ingredients that help support weight control and maintain energy levels, providing pets with the health benefits they need to live a healthy and happy life.

 

Similarly, Natural Pet Science’s Calm’Cat is a scrumptious and safe alternative for cat owners looking to keep their furry friend’s anxiety at bay without using harmful substances. The calming formula extracts proteins, fibers and calming properties from natural sources, like valerian root and chamomile flowers, to keep pets in a happy mood throughout the day. Pet owners can purchase Slim’Dog and Calm’Cat treats through online retailers Well and Amazon and at independent retail stores across Canada.

 

It doesn’t stop there. Natural Pet Science, the pet-focused arm under premium Canadian health company EastWest Science, will soon release more pet treat formulas boasting equally smart, healthy recipes that are natural and delicious. Future Natural Pet Science pet treats to look out for are Chill’Dog, Play’n Dog, Quick’Cat and Happy’Cat.

 

 

Can CBD Dog Treats Help Ease your Dog’s Pain and Anxiety?

COLORADO: It’s difficult to watch our pets age. They provide so much unconditional love and support, we can’t imagine living our lives without them. As we watch them age, we can’t help but recall their younger years as puppies, when they would bounce and frolic about. While we can’t bring back our dog’s youth, we can help ease the pain of old age and anxiety caused by modern life.

We don’t intentionally let our dogs suffer, but it’s hard to tell exactly what they need because they can’t talk. Oftentimes, we do feel the pain and stress that they are experiencing, just by looking in their eyes. It doesn’t help that modern dog food often uses cheap fillers and poor ingredients that can compromise our dog’s health.

Fortunately for us loving dog owners, modern technology is unlocking the secrets of the hemp plant to ease the suffering and pain our dogs experience but can’t describe to us in words.

Scientists have discovered how a compound in hemp called cannabidiol, or CBD, can help our dogs with a wide range of pain and stress-related issues. These issues include separation anxiety, old-age related pain, i.e., arthritis or hip and joint pain. Another benefit of hemp-based CBD dog treats and biscuits is that they help calm dogs that are anxious from the frightening noise from fireworks or thunderstorms.

Dr. Axe, a prominent celebrity physician based in Nashville, TN, had this to say about CBD in a recent article on his site, “Research shows that CBD benefits include acting as an anti-inflammatory, anticonvulsant, antioxidant, antiemetic, anxiolytic and antipsychotic agent, and is therefore a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia.”

A common erroneous concern about CBD is that it will make your dog high. However, CBD by itself contains no THC, the active ingredient in marijuana that creates the sensation of being high. So you can rest assured your dog has the ability to stay calm, but clear-headed when enjoying a hemp-based CBD dog biscuit or treat.

Pot-Based Dog Treats: Owners Claim They Cure Pets’ Ailments

CALIFORNIA:  Some pet owners are claiming that hemp-based treats cure many of their pets’ ailments. The treats are infused with cannabinoids or CBDs but don’t have THC, so the animal doesn’t get high. One of the hemp-based treat brands called Treatibles has been used by some owners for anxiety or stress in their dogs. Andrew Mizia stated that his dog Fred can be stressed when around other dogs, and he stated the following regarding the result when he gives the canine the treat, according to ABC Channel 7.

These treats are flying off the shelves, because many pet owners have claimed that the treats can cure illnesses ranging from arthritis to epileptic seizures. The manager of one store that carries a large variety of calming treats claims that the Treatibles are more effective in treating anxious animals because of the cannabinoids. The manager of the Holistic Hound, a store in Oakland, Dianne Krenzer, stated the following. “I’ve never seen a product that has had such broad popularity and interest. Humans and animals have an endocannabinoid system and we have receptors throughout our bodies. So if anxiety is an issue, the CBD works on the stress receptors.”

The treats are intended primarily for dogs, but have even been used with other domestic and farm animals. They contain 40mg of CBD per treat. The manufacturer recommends one treat per 20 pounds. And some owners even rave about the success they’ve had with the treats in saving their animal’s lives. An owner named Wendy who has a 15-year-old lab mix named Kali decided to try the treats out of desperation, as she had scheduled an appointment to euthanize the dog in order to alleviate its chronic pain. Wendy stated the following, according to the Examiner.

 

FDA Advances Work Related To Cannabidiol Products With Focus On Protecting Public Health, Providing Market Clarity

DISTRICT OF COLUMBIA: Over the past year, the U.S. Food and Drug Administration has embarked on a comprehensive evaluation of cannabidiol (CBD) products, with a focus on educating the public about the risks and unknowns of these products, gathering the science needed to better understand both these safety concerns and potential benefits to inform our regulatory approach, as well as taking steps when necessary to address products that violate the law in ways that raise a variety of public health concerns.

Today, we are providing updates on our efforts in this area, including several new steps in areas of education, research and enforcement with the ultimate goal of continuing to protect the public health and working to provide market clarity.

Educating the Public About Potential Risks of Using CBD

We’re seeing CBD being marketed in a number of different products, such as oil drops, capsules, syrups, food products, such as chocolate bars and teas, cosmetics and other topical lotions and creams, as well as products marketed for pets and other animals – and we understand consumers are seeking out these novel products for a variety of perceived health-related or other reasons.

But as the agency has stated before, we are concerned that some people wrongly think that the myriad of CBD products on the market have been evaluated by the FDA and determined to be safe, or that using CBD ‘can’t hurt.’ Aside from one prescription drug approved to treat two rare, severe pediatric epilepsy disorders, no other CBD products have been evaluated or approved by the FDA.

We remain focused on educating the public about the number of questions that remain regarding CBD’s safety. There may be risks that need to be considered before using CBD products outside of the monitored setting of a prescription from your health care provider.

In particular, the agency recently updated the public on concerns about potential harm from CBD products, including potential liver injury, interactions with other drugs and male reproductive toxicity, as well as side effects such as drowsiness. In addition, there is still much we do not know about other potential risks. For example, other than the approved prescription drug, we know little about the potential effects of sustained and/or cumulative use of CBD, co-administration with other medicines, or the risks to vulnerable populations like children, pregnant and lactating women, the elderly, unborn children and certain animal populations. This does not mean that we know CBD is unsafe to these populations or under these circumstances, but given the gaps in our current knowledge, and the known risks that have been identified, we also are not at a point where we can conclude that unapproved CBD products are safe for use. We encourage Americans to consult with their health care providers before using CBD products.

We will continue to expand our educational efforts on this front. This includes consumers broadly, specific populations where there are additional, important health considerations, as well as health care professionals who must understand these risks when talking to their patients. We will also continue to update our online resources for consumers, researchers and industry, as well as sustain multiple lines of communication with Congress, industry, researchers and our regulatory partners at the federal, state, local, territorial, tribal and international levels to share and collect needed information and hear a variety of perspectives.

Closing Knowledge Gaps in Both Safety and Potential Benefits

The marketplace for CBD-containing products is quickly evolving and it is critical that we work together with stakeholders and industry to develop high-quality data to close the knowledge gaps about the science, safety and quality of many of these products, as well as further evaluate any potential benefits outside of the one FDA-approved drug product to treat two rare, severe pediatric epilepsy disorders.

To address the questions and concerns we’ve already raised, we’re seeking reliable and high-quality data. This includes data on, among other things: the sedative effects of CBD; the impacts of long-term sustained or cumulative exposure to CBD; transdermal penetration and pharmacokinetics of CBD; the effect of different routes of CBD administration (e.g., oral, topical, inhaled) on its safety profile; the safety of CBD for use in pets and food-producing animals; and the processes by which “full spectrum” and “broad spectrum” hemp extracts are derived, what the content of such extracts is, and how these products may compare to CBD isolate products.

Given the importance of answering these questions, we’re exploring a number of ways to address the data gaps as quickly as possible. This includes encouraging, facilitating and initiating more research on CBD, providing venues for industry and researchers to share new data with the agency and identifying opportunities to further collaborate with our federal partners at Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration and National Institute on Drug Abuse on this important issue.

Importantly, the Agriculture Improvement Act of 2018 – which, among other things, changed federal law so that cannabis and cannabis derivatives with very low levels of the psychoactive intoxicating component of cannabis, delta-9 tetrahydrocannabinol (THC) are no longer controlled substances – has opened significant new opportunities for research, and as that body of research develops and grows, there will be considerably more information available. In particular, there’s been an increased interest in drug development from CBD and other compounds found in cannabis and we are working to support drug development as much as possible.

First, given all the research and activity in this space, we are taking new steps to provide a public and transparent way for stakeholders to provide new and emerging information to us in real time as it becomes available. To this end, in the coming days we are re-opening the public docket we established for our May 2019 public hearing. The docket provides a valuable conduit for submission of scientific data on CBD to the agency, so we have decided to extend the comment period indefinitely to allow the public to comment and to share relevant data with the agency. As the agency continues to move forward to explore viable pathways for CBD products outside the drug context, this extension will allow stakeholders to continue to provide relevant data as research in this area evolves.

This docket also includes a mechanism for a stakeholder to submit data or information that the stakeholder believes to be confidential. We hope that this will enable responsible industry participants, academic researchers, and other stakeholders to share relevant information with the FDA – including information about specific products, which could help inform appropriate regulatory steps.

We also are working to generate data to help inform our work in this area. For example, the FDA’s Office of the Chief Scientist recently awarded a grant to the FDA’s National Center for Toxicological Research to conduct a study to better understand the effects of CBD exposure during pregnancy. Additionally, we’ve initiated a research study in partnership with the University of Mississippi to evaluate the levels of CBD and THC in a sample of cosmetic products to assess sensitization of THC and CBD topically, and dermal penetration.

As data become available that are high-quality, reliable and relevant to our evaluation of CBD products that fall under the FDA’s purview, we will be able to refine – and, perhaps in some cases, revise – our thinking and approaches.

Monitoring the Marketplace with a Focus on Greatest Risk to Public Harm

As we work to educate the public and close the knowledge gaps to further guide our approach to CBD products, we will continue to monitor the marketplace and take appropriate action against unlawful CBD products that pose a risk of harm to the public.

We have seen many CBD products being marketed with claims of therapeutic benefit, such as treating or curing serious diseases such as cancer and Alzheimer’s disease, or other drug claims, without having gone through the drug approval process. The proliferation of such products may deter consumers from seeking proven, safe medical therapies for serious illnesses – potentially endangering their health or life.

We also have serious concerns about products that put the public at risk in other ways. For example, we are aware of the risks posed by product contaminants such as heavy metals, THC or other potentially harmful substances. We also have significant concerns about products marketed with false claims or statements such as omitted ingredients, incorrect statements about the amount of CBD, products marketed for use by vulnerable populations like children or infants, and products that otherwise put the public health at risk.

As we move forward, we are currently evaluating issuance of a risk-based enforcement policy that would provide greater transparency and clarity regarding factors the agency intends to take into account in prioritizing enforcement decisions. Any enforcement policy would need to further the goals of protecting the public and providing more clarity to industry and the public regarding the FDA’s enforcement priorities while we take potential steps to establish a clear regulatory pathway.

Conclusion

Our ongoing efforts related to CBD, including the steps we’re announcing today, are in line with our mission to protect the public, foster innovation and promote consumer confidence. We recognize the significant public interest in CBD and we must work together with stakeholders and industry to develop high-quality data to close the substantial knowledge gaps about the science, safety and quality of many of these products. We are committed to working efficiently to further clarify our regulatory approach to these products – as always, using science as our guide and upholding our rigorous public health standards.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Select CBD Line By Cura Now Sold At New Seasons Market’s 21 Stores

OREGON: Select CBD, an industry-leading hemp-derived CBD brand by Cura Wellness, proudly announces its partnership with New Seasons Market to provide products for sale at New Seasons neighborhood grocery stores in Oregon, California and Washington. Customers can purchase Select’s hemp-derived line of Select CBD Drops, Select PETS Drops, Select Muscle Rub and Montel by Select CBD Capsules.

Select CBD products are hemp-derived and contain zero percent THC. The brand pairs naturally extracted essences with CBD rich oil, capturing the synergy between herbs and CBD. Like New Seasons, Select prides itself on sourcing only the best quality local products from local sustainable farmers. Select also tests its products to the most stringent testing standards in the country; namely the Oregon pesticide, residual alcohol, and microbial panel. All products are quality control batch tested at State & Federal levels through The Oregon Environmental Laboratory Accreditation Program (ORELAP) accredited testing labs near our headquarters in Portland, Oregon.

Screenshot 2019-02-13 09.00.49

“Cura’s Select CBD products are a natural fit for our wellness department, with their commitment to quality and a clean extraction process,” said New Seasons Market Nutritionist Amanda Nelson. “New Seasons customers can be confident that our Select CBD offerings are locally sourced and made from hemp and essential oils.”

New Seasons customers in Oregon, California and Washington can find the following Cura products at their local store:

  • Select CBD Drops – One of Select’s most popular products, Select CBD Drops contain 1,000 mg of CBD and are infused with herbs and essential oils. Options include Lavender, Lemon-Ginger, Peppermint and Unflavored tinctures.
  • Select Muscle Rub – Select’s newest CBD product is a soothing blend of pure hemp-derived CBD, Aloe, Vitamin E, Tea Tree oil, Menthol and more.
  • Select PETS – Available in Chicken, Bacon, Peanut Butter, Salmon and Unflavored options, Select PETS contains 750 mg of hemp-derived CBD formulated for all animals with endocannabinoid systems.
  • Montel by Select CBD Capsules – Available in a RELAX or ALERT formulation, this line was developed using a unique blend of terpenes, hemp-derived CBD and high-quality bioavailable gel caps.

“What makes this partnership especially exciting for us is the fact that both the Select and New Seasons brands grew from big dreams in Portland, Oregon to companies operating on a larger scale,” said Cura Chief Executive Officer Cameron Forni. “Our organizations’ values are very similar regarding employees, product and culture and it’s so exciting to see Select on the shelves of such a welcoming store.”

Cannabis Legal Trends To Watch In 2018

By Sharon Golden

Ever since you were young, your family was very problematic. There was never a day when you didn’t hear your parents shouting and arguing with each other. You would often lock yourself in your room as an escape from all the tension in the house. You’d rather be alone rather than be in a situation where everyone around you is shouting. As you got a little older, you opted to use marijuana to relieve the stress, anxiety and fear that your family brings you. This has been legal in the state you’re living, so you don’t worry about violating any laws whenever you use marijuana. Because of this, marijuana has become your escape whenever things don’t go according to plan. You’ve been using this almost every day because the relief it gives you is exceptional. Since you’re looking forward to use marijuana in the coming years, you’re very curious on the marijuana legal trends to watch in 2018. You’re excited to know how you can use marijuana in more ways than one.

  1. Marijuana will be used in sports: Sports organizations have gradually acknowledged the fact that marijuana has helped players in treating physical ailments and improve the condition of their nervous system. Aside from that, marijuana has been used in the past to treat sports-related injuries. Yes, marijuana can do all of those things. Some of the players who have been using marijuana are Bryon Morris, Michael Phelps and Nick Diaz. Additionally, National Basketball Association (NBA) has already given a statement which now allows their players to use marijuana. Given that the NBA is one of the most recognizable sports organizations in the world, it won’t be long before other organizations will also follow their lead!
  1. Marijuana will be used in healthcare: More and more health professionals are slowly adapting marijuana in some of their medical treatments. It has been found that marijuana is effective in treating medical conditions such as muscle spasms, nausea and even Crohn’s disease. Researcher is also in the works to determine what other ailments or diseases can be treated with medical marijuana. As such, you can expect that medical marijuana will be prominent in different states across the globe by 2018.
  1. Marijuana will be taught in schools: Yes, you’ve read that right. Because marijuana has made notable advancements in the medical and recreational markets, there are certain states  which offer marijuana-related college courses. In California for example, a university in Irvine is currently developing an interdisciplinary research center which aims to investigate marijuana. Consumers can also educate themselves with marijuana classes and tours that allows them to learn about the differences of using marijuana medicinally and recreationally. With all of these efforts, more people will learn about the benefits of marijuana and will no longer consider the drug as something that deteriorates health.
  1. Marijuana will be in pet food and treats: Not only is marijuana beneficial to human beings but to pets, too. The number of pet owners who find the medical advantages of using hemp formulas is gradually increasing and demand is developing quickly. The industry is now seeing an increase of companies which would produce and sell wellness items for pets which contains marijuana as one of the main ingredients.
  1. CBD oils will be successful: Cannabidiol is the part of the marijuana plant that doesn’t cause the certain side effects associated with marijuana use. Because of this, CBD oils are now used in medical marijuana to treat pain or the symptoms associated with chemotherapy. With the ever-changing marijuana map and the progress of research in marijuana in the field of medicine, the CBD oil industry is expected to have a boost in profits in the coming years.
  1. Marijuana will be available in deliveries: You can now purchase marijuana in different ways and one way of doing this is by having it delivered to your doorstep. There are also big players in the industry which funded millions of dollars to allow marijuana to have a delivery service and to fulfill all of your marijuana needs right in the comforts of your home!
  1. Marijuana will be in holistic and wellness products for you: You can now soothe your body, mind and soul with marijuana as this will be present in body creams, shampoos and even supplements. You’ll have more ways of enjoying your favorite marijuana!

For sure, you’ll be able to use marijuana in different ways this 2018. There are now a lot of mediums available on how you can enjoy marijuana. Since this is legal in your state, no one will ever hinder you from using it the way you want. You can have the liberty to use marijuana wherever, whenever. So if this is the only drug that gives you pleasure, go ahead and indulge yourself!

However, there are some states around the world where it is illegal to use cannabis in any way. If you or you know someone who has been involved with the law due to cannabis use, this website can be of very great help.


Sharon Golden has been a law writer and businesswoman for more than 20 years, and she is currently working on his next big project. Her pieces offer knowledge on various law topics that are easily understandable to the common reader. Sharon cannot be separated from Sophia, their family dog. When Sharon has the time, she’s always seen walking Sophia around the city.

Veterinary Cannabinoid Therapeutics Takes Center Stage At Cannabis in Veterinary Medicine Symposium

A panel of seven Colorado doctors discuss using cannabis with animals

COLORADO: Roughly 3-5% of all dogs have genetic epilepsy, and 14 million dogs have some form of arthritis. CBD oil is helping millions of people around the world, and as a result the veterinary medical market is becoming more aware of the relief CBD can provide to dogs, cats, horses and even birds! Animals have an endocannabinoid system much like humans and can benefit from cannabinoids in much the same way. But don’t be so quick to give your pet just any form of cannabis, THC can be toxic to animals, so ensuring that your pet receives a veterinary approved formulation is important.

Dr. Silver is quoted as saying: “We have learned that the quality of the raw material providing the cannabinoids and terpenes plays the most important role to ensure successful clinical outcomes in our pets and farm animals. The ZERO THC full spectrum hemp oil from Folium Biosciences is, in my experience, one of the top hemp oil raw materials in the USA, and is absolutely safe due to it containing no THC. Numerous reports over the past 5 years have documented the potential toxicity of THC to our pets. There have been a few deaths due to THC ingestion from well-meaning pet parents giving their pets some of their own medical marijuana.”

Folium Biosciences is leading the animal health industry in providing bulk cannabidiol (CBD) based formulations to its customers. Led by Dr. Silver, the Folium Biosciences Animal Health Division provides the leading brands in both the cannabis industry as well as the animal health industry, with unique Zero THC formulations to be used in supplements for pets. Dr. Silver is working closely with fellow veterinarians across the country to ensure that CBD research in pets becomes more widely conducted, and he is working actively with the veterinary research community to help create successful animal health studies and clinical trials.

Pharmacist Launches New CBD Company, Honest Herbal; Takes Top Honors in DOPE Competition

COLORADO: Kristy Redmon, Honest Herbal president, founder and a registered pharmacist, announced that the company is the recipient of two DOPE Cup Colorado awards. The full-spectrum CBD hemp company placed first in the Best CBD Edible category for its capsules and took second place for Best Transdermal Cream.

“We were thrilled to have our products recognized in the DOPE Cup competition,” said Redmon. “As a new company, we had no idea what to expect. To have won a first and second place was an honor and an affirmation to our philosophy of providing consistent, fully tested and trustworthy CBD hemp products.” The awards are especially impressive as they come just a few months after Honest Herbal’s official launch.

All of Honest Herbal’s products are pharmacist formulated from cannabinoid rich industrial hemp, making them legal in all 50 states. Honest Herbal’s in-house breeding program has produced strains of CBD flower that are high in CBD yet low in THC. The results are products with all the beneficial health and wellness properties, yet without the psychoactive elements inherent in cannabis, with which most people are familiar.

Honest Herbal offers CBD Hemp Oil Capsules available in strengths of 12.5mg. and 25mg. For pets or those who prefer a liquid form, Honest Herbal offers a 30ml CBD Hemp Extract, complete with a calibrated dropper for accurate dosing.

Honest Herbal’s CBD Muscle & Joint Cream is a transdermal formulation that is easily and quickly absorbed through the skin and is one of the most potent CBD topicals in the industry. Consumers can also take advantage of the company’s luxurious and nourishing CBD Infused Hand and Body Lotion that can be used every day.

Honest Herbal grows, processes, and produces its entire product line giving the company the unique ability to ensure the quality of its products from their inception all the way to store shelves. Wholesaler inquiries are now being accepted on the company website.

 

4th Annual Cannabis World Congress & Business Exposition In New York City Opens Registration

NEW JERSEY: Registration is now open for the only trade show and conference in New York focused on the business of cannabis, the 4th Annual Cannabis World Congress & Business Exposition (CWCBExpo) will take place June 14-16, 2017 at the Javits Convention Center in New York, NY.  Serving the East Coast, CWCBExpo NY will create a dynamic marketplace filled with the best education, products, and resources.  Aspiring cannabis entrepreneurs, healthcare professionals, investors, equity partners, ancillary businesses, and agricultural opportunists that can profit from this nascent industry, as well as those already in the business can register now for early bird rates here.

“This June, no other show in the Northeast will offer the depth and breadth of information and products for these industries expected to top $20 billion in the next three years,” said Scott Giannotti, Managing Director of the CWCBExpo events. “Our platform will continue to provide valuable education about all aspects of the cannabis plant, as we’ve done for the last four years, but this year we’ve taken a more comprehensive approach to learning that will take our attendees from A-to-Z as well as added a strong emphasis on industrial hemp due to Governor Cuomo’s commitment to making hemp a $1 billion industry in our state. It’s a very exciting time for New York.”

Led by industry experts in cultivation, business-building, science, policy, medicine, law, and investment, the CWCBExpo NY conference program (June 15-16) made up of curated panel presentations, lectures, and interactive discussions, will cover the five main sectors of the cannabis industry: Cultivation, Processing, Sales, Ancillary Businesses, and Advocacy and Legislation. The CWCBExpo NY conference program will also offer headlining Keynote speakers and thought-leadership panels. Some of our thought-leadership panels will include: Real Estate in the Cannabis Industry, Women and Technology, Professional Athletes and Cannabis, and Teaching Cannabis in Mainstream Education.

The CWCBExpo signature workshops on June 14th will take deep dives into medical cannabis, investing into the cannabis industry, industrial hemp, and a sophisticated recreational use workshop:

  • Comprehensive Medical Cannabis and Cannabinoid Training,” led by Healthway Education Systems (CME accredited)
  • “Following the Money in Cannabis: Where and How to Invest in the Cannabis Industry and Raise Capital for Your Cannabis Business,” presented by Viridian Capital Advisors
  • Make America Hemp Again” presented by Hoban Law Group / CPS Education

For the first time, CWCBExpo NY will offer a post-event workshop on Saturday, June 17th covering: “The Art of the Cannabis Sommelier: Interpening,” presented by Trichrome Institute.

CWCBExpo NY, taking place under one roof, in the financial and media capitol of the world, will also host an expanded exhibit floor (June 15-16) with suppliers in the industry showcasing cutting-edge products and services to those in the business, entrepreneurs looking to enter the market, medical professionals, dispensary owners, retailers, investors, and providers of professional services.  Featured exhibitors participating in the CWCBExpo NY include: Elixinol (Gold & Press Room Sponsor), Greenspoon Marder (Lanyard Sponsor), Airganics, Amercanex, CBD for Life, CannaKorp, HempMeds, Labscape, MJ Freeway, and TrueLeaf Pets, to name a few.  The CWCBExpo is also partnering with leading industry associations including  the Marijuana Business Association (MJBA), Cannabis and Hemp Association, National Indian Cannabis Coalition, and Women Grow.

Steep early bird registration discounts are in effect until February 13th.